 | • レポートコード：MRC2312MG04330 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、68ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の分子残留疾患検出装置市場規模と予測を収録しています。・世界の分子残留疾患検出装置市場：売上、2018年-2023年、2024年-2029年 ・世界の分子残留疾患検出装置市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の分子残留疾患検出装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「腫瘍情報アッセイ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 分子残留疾患検出装置のグローバル主要企業は、Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、分子残留疾患検出装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の分子残留疾患検出装置市場：タイプ別、2018年-2023年、2024年-2029年 世界の分子残留疾患検出装置市場：タイプ別市場シェア、2022年 ・腫瘍情報アッセイ、腫瘍診断アッセイ 世界の分子残留疾患検出装置市場：用途別、2018年-2023年、2024年-2029年 世界の分子残留疾患検出装置市場：用途別市場シェア、2022年 ・予後予測、術後補助療法決定、術後再発サーベイランス、その他 世界の分子残留疾患検出装置市場：地域・国別、2018年-2023年、2024年-2029年 世界の分子残留疾患検出装置市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における分子残留疾患検出装置のグローバル売上、2018年-2023年 ・主要企業における分子残留疾患検出装置のグローバル売上シェア、2022年 ・主要企業における分子残留疾患検出装置のグローバル販売量、2018年-2023年 ・主要企業における分子残留疾患検出装置のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciences ************************************************************* ・調査・分析レポートの概要 分子残留疾患検出装置市場の定義 市場セグメント 世界の分子残留疾患検出装置市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の分子残留疾患検出装置市場規模 世界の分子残留疾患検出装置市場規模：2022年 VS 2029年 世界の分子残留疾患検出装置市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの分子残留疾患検出装置の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の分子残留疾患検出装置製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：腫瘍情報アッセイ、腫瘍診断アッセイ 分子残留疾患検出装置のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：予後予測、術後補助療法決定、術後再発サーベイランス、その他 分子残留疾患検出装置の用途別グローバル売上・予測 ・地域別市場分析 地域別分子残留疾患検出装置市場規模 2022年と2029年 地域別分子残留疾患検出装置売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Adaptive、 Guardant Health、 Invitae、 Cergentis B.V、 LexentBio、 Natera、 BGI、 Zhiben Medical、 Burning Rock Medicine、 Huidu Medical、 Zhenhe Technology、 ExactSciences ... |
This research report provides a comprehensive analysis of the Molecular Residual Disease Detection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Molecular Residual Disease Detection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Molecular Residual Disease Detection, challenges faced by the industry, and potential opportunities for market players.
The global Molecular Residual Disease Detection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Molecular Residual Disease Detection market presents opportunities for various stakeholders, including Prognosis, Adjuvant Treatment Decision-Making. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Molecular Residual Disease Detection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Molecular Residual Disease Detection market was valued at US$ 4414.1 million in 2022 and is projected to reach US$ 12700 million by 2029, at a CAGR of 16.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Molecular Residual Disease Detection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Molecular Residual Disease Detection market.
Market Overview: The report provides a comprehensive overview of the Molecular Residual Disease Detection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tumor-informed Assays, Tumor-agnostic Assays), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Molecular Residual Disease Detection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Molecular Residual Disease Detection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Molecular Residual Disease Detection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Molecular Residual Disease Detection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Molecular Residual Disease Detection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Molecular Residual Disease Detection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Molecular Residual Disease Detection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Molecular Residual Disease Detection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Molecular Residual Disease Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tumor-informed Assays
Tumor-agnostic Assays
Market segment by Application
Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other
Global Molecular Residual Disease Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Residual Disease Detection, market overview.
Chapter 2: Global Molecular Residual Disease Detection market size in revenue.
Chapter 3: Detailed analysis of Molecular Residual Disease Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Residual Disease Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Molecular Residual Disease Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Residual Disease Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Residual Disease Detection Overall Market Size
2.1 Global Molecular Residual Disease Detection Market Size: 2022 VS 2029
2.2 Global Molecular Residual Disease Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Residual Disease Detection Players in Global Market
3.2 Top Global Molecular Residual Disease Detection Companies Ranked by Revenue
3.3 Global Molecular Residual Disease Detection Revenue by Companies
3.4 Top 3 and Top 5 Molecular Residual Disease Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Residual Disease Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Residual Disease Detection Players in Global Market
3.6.1 List of Global Tier 1 Molecular Residual Disease Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Residual Disease Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Molecular Residual Disease Detection Market Size Markets, 2022 & 2029
4.1.2 Tumor-informed Assays
4.1.3 Tumor-agnostic Assays
4.2 By Type – Global Molecular Residual Disease Detection Revenue & Forecasts
4.2.1 By Type – Global Molecular Residual Disease Detection Revenue, 2018-2023
4.2.2 By Type – Global Molecular Residual Disease Detection Revenue, 2024-2029
4.2.3 By Type – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
5.1.2 Prognosis
5.1.3 Adjuvant Treatment Decision-Making
5.1.4 Surveillance for Postoperative Recurrence
5.1.5 Other
5.2 By Application – Global Molecular Residual Disease Detection Revenue & Forecasts
5.2.1 By Application – Global Molecular Residual Disease Detection Revenue, 2018-2023
5.2.2 By Application – Global Molecular Residual Disease Detection Revenue, 2024-2029
5.2.3 By Application – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
6.2 By Region – Global Molecular Residual Disease Detection Revenue & Forecasts
6.2.1 By Region – Global Molecular Residual Disease Detection Revenue, 2018-2023
6.2.2 By Region – Global Molecular Residual Disease Detection Revenue, 2024-2029
6.2.3 By Region – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Molecular Residual Disease Detection Revenue, 2018-2029
6.3.2 US Molecular Residual Disease Detection Market Size, 2018-2029
6.3.3 Canada Molecular Residual Disease Detection Market Size, 2018-2029
6.3.4 Mexico Molecular Residual Disease Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Molecular Residual Disease Detection Revenue, 2018-2029
6.4.2 Germany Molecular Residual Disease Detection Market Size, 2018-2029
6.4.3 France Molecular Residual Disease Detection Market Size, 2018-2029
6.4.4 U.K. Molecular Residual Disease Detection Market Size, 2018-2029
6.4.5 Italy Molecular Residual Disease Detection Market Size, 2018-2029
6.4.6 Russia Molecular Residual Disease Detection Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Residual Disease Detection Market Size, 2018-2029
6.4.8 Benelux Molecular Residual Disease Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Molecular Residual Disease Detection Revenue, 2018-2029
6.5.2 China Molecular Residual Disease Detection Market Size, 2018-2029
6.5.3 Japan Molecular Residual Disease Detection Market Size, 2018-2029
6.5.4 South Korea Molecular Residual Disease Detection Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Residual Disease Detection Market Size, 2018-2029
6.5.6 India Molecular Residual Disease Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Molecular Residual Disease Detection Revenue, 2018-2029
6.6.2 Brazil Molecular Residual Disease Detection Market Size, 2018-2029
6.6.3 Argentina Molecular Residual Disease Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Molecular Residual Disease Detection Revenue, 2018-2029
6.7.2 Turkey Molecular Residual Disease Detection Market Size, 2018-2029
6.7.3 Israel Molecular Residual Disease Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Residual Disease Detection Market Size, 2018-2029
6.7.5 UAE Molecular Residual Disease Detection Market Size, 2018-2029
7 Molecular Residual Disease Detection Companies Profiles
7.1 Adaptive
7.1.1 Adaptive Company Summary
7.1.2 Adaptive Business Overview
7.1.3 Adaptive Molecular Residual Disease Detection Major Product Offerings
7.1.4 Adaptive Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.1.5 Adaptive Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Molecular Residual Disease Detection Major Product Offerings
7.2.4 Guardant Health Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Invitae
7.3.1 Invitae Company Summary
7.3.2 Invitae Business Overview
7.3.3 Invitae Molecular Residual Disease Detection Major Product Offerings
7.3.4 Invitae Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.3.5 Invitae Key News & Latest Developments
7.4 Cergentis B.V
7.4.1 Cergentis B.V Company Summary
7.4.2 Cergentis B.V Business Overview
7.4.3 Cergentis B.V Molecular Residual Disease Detection Major Product Offerings
7.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.4.5 Cergentis B.V Key News & Latest Developments
7.5 LexentBio
7.5.1 LexentBio Company Summary
7.5.2 LexentBio Business Overview
7.5.3 LexentBio Molecular Residual Disease Detection Major Product Offerings
7.5.4 LexentBio Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.5.5 LexentBio Key News & Latest Developments
7.6 Natera
7.6.1 Natera Company Summary
7.6.2 Natera Business Overview
7.6.3 Natera Molecular Residual Disease Detection Major Product Offerings
7.6.4 Natera Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.6.5 Natera Key News & Latest Developments
7.7 BGI
7.7.1 BGI Company Summary
7.7.2 BGI Business Overview
7.7.3 BGI Molecular Residual Disease Detection Major Product Offerings
7.7.4 BGI Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.7.5 BGI Key News & Latest Developments
7.8 Zhiben Medical
7.8.1 Zhiben Medical Company Summary
7.8.2 Zhiben Medical Business Overview
7.8.3 Zhiben Medical Molecular Residual Disease Detection Major Product Offerings
7.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.8.5 Zhiben Medical Key News & Latest Developments
7.9 Burning Rock Medicine
7.9.1 Burning Rock Medicine Company Summary
7.9.2 Burning Rock Medicine Business Overview
7.9.3 Burning Rock Medicine Molecular Residual Disease Detection Major Product Offerings
7.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.9.5 Burning Rock Medicine Key News & Latest Developments
7.10 Huidu Medical
7.10.1 Huidu Medical Company Summary
7.10.2 Huidu Medical Business Overview
7.10.3 Huidu Medical Molecular Residual Disease Detection Major Product Offerings
7.10.4 Huidu Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.10.5 Huidu Medical Key News & Latest Developments
7.11 Zhenhe Technology
7.11.1 Zhenhe Technology Company Summary
7.11.2 Zhenhe Technology Business Overview
7.11.3 Zhenhe Technology Molecular Residual Disease Detection Major Product Offerings
7.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.11.5 Zhenhe Technology Key News & Latest Developments
7.12 ExactSciences
7.12.1 ExactSciences Company Summary
7.12.2 ExactSciences Business Overview
7.12.3 ExactSciences Molecular Residual Disease Detection Major Product Offerings
7.12.4 ExactSciences Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.12.5 ExactSciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer